Botulinum toxin treatment for oropharyngeal dysphagia in patients with stroke

Neurogastroenterology and Motility

Volumn 25, Issue 11, 2013, Pages

  Terre R ^a   Panades A ^a   Mearin, F ^a  

^a University Institute affiliated with the Autonomous University of Barcelona   (Spain)

Author keywords

Botulinum toxin; Cricopharyngeus muscle; Dysphagia; Stroke; Videofluoroscopy

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL EVALUATION; DYSPHAGIA; ESOPHAGUS MANOMETRY; FEMALE; FOLLOW UP; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PYRIFORM SINUS; STOMACH TUBE; UPPER ESOPHAGUS SPHINCTER;

BOTULINUM TOXIN; CRICOPHARYNGEUS MUSCLE; DYSPHAGIA; STROKE; VIDEOFLUOROSCOPY;

ADULT; AGED; BOTULINUM TOXINS, TYPE A; DEGLUTITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MANOMETRY; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84884985008     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12213     Document Type: Article

References (48)

1. Terré R, Mearin F. Oropharyngeal dysphagia after the acute phase of stroke: predictors of aspiration. Neurogastroenterol Motil 2006; 18: 200-5.
2. Daniels SK, Schroeder MF, McClain M, Corey DM, Rosenbek JC, Foundas AL. Dysphagia in stroke: development of a standard method to examine swallowing recovery. J Rehabil Res Dev 2006; 43: 347-56.
3. Smithard DG. Swallowing and stroke. Neurological effects and recovery. Cerebrovasc Dis 2002; 14: 1-8.
4. Terré R, Mearin F. Resolution of tracheal aspiration after the acute phase of stroke-related oropharyngeal dysphagia. Am J Gastroenterol 2009; 104: 923-32.
5. Williams RBH, Wallace KL, Ali GN, Cook IJ. Biomechanics of failed deglutitive upper esophageal sphincter relaxation in neurogenic dysphagia. Am J Physiol Gastrointest Liver Physiol 2002; 283: 16-26.
6. Lacau St Guily J, Willing TN, Chaussade S, Eymard B, Angelard B. Swallowing disorders in muscular diseases: functional assessment and indication of cricopharyngealmyotomy. Ear Nose Throat J 1994; 73: 34-40.
7. Wilson JA, Alan PL, Maran AG. Cricopharyngeal dysfunction. Otolaryngol Head Neck Surg 1992; 106: 163-8.
8. Murry T, Wasserman T, Carrau RL, Castillo B. Injection of botulinum toxin A for the treatment of dysfunction of the upper esophageal sphincter. Am J Otolaryngol 2005; 26: 157-62.
9. Leonard R, Kendall K, McKenzie A, Goodrich S. The treatment plan. In Leonard R, ed. Dysphagia Assessment and Treatment Planning. A Team Approach. San Diego, CA: Plural Publishing, 2008: 295-336.
10. Logemann JA. Management of the patient with oropharyngeal swallowing disorders. In: Logemann JA, ed. Evaluation and Treatment of Swallowing Disorders, 2nd ed. Austin, TX: Pro-ed, 1998: 307-26.
11. Singh S, Hamdy S. Dysphagia in stroke patients. Postgrad Med J 2006; 82: 383-91. Review.
12. Shaker R, Easterling C, Kern M et al. Rehabilitation of swallowing by exercise in tube-fed patients with pharyngeal dysphagia secondary to abnormal UES opening. Gastroenterology 2002; 122: 1314-21.
13. McKenna JA, Dedo HH. Cricopharyngeal myotomy: indications and technique. Ann Otol Rhinol Laryngol 1992; 101: 216-21.
14. Woodson G. Cricopharyngeal myotomy and arytenoid adduction in the management of combined laryngeal and pharyngeal paralysis. Otolaryngol Head Neck Surg 1997; 116: 339-43.
15. Singer MI, Blom ED, Hamaker RC. Pharyngeal plexus neurectomy for a laryngeal speech rehabilitation. Laryngoscope 1986; 96: 50-4.
16. Ahsan SF, Meleca RJ, Dworkin JP. Botulinum toxin injection of the cricopharyngeus muscle for the treatment of dysphagia. Otolaryngol Head Neck Surg 2000; 122: 691-5.
17. Parameswaran MS, Soliman AM. Endoscopic botulinum toxin injection for cricopharyngeal dysphagia. Ann Otol Rhinol Laryngol 2002; 111: 871-4.
18. Schneider I, Thumfart WF, Pototschnig C, Eckel HE. Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method. Ann Otol Rhinol Laryngol 1994; 103: 31-5.
19. Van den Bergh P, Francart J, Mourin S, Kollmann P, Laterre EC. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Muscle Nerve 1995; 18: 720-9.
20. Borodic GE, Francart J, Mourin S, Kollmann P, Laterre EC. Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread. Head Neck 1990; 12: 392-9.
21. Blitzer A, Brin MF, Fahn S, Lovelace RE. Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia). Laryngoscope 1988; 98: 193-7.
22. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995; 332: 774-8.
23. Cuilliere C, Ducrotté P, Zerbib F et al. Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut 1997; 41: 87-92.
24. Zarate N, Mearin F, Baldovino F, Armengol JR, Malagelada JR. Achalasia treatment in the elderly: is botulinum toxin injection the best option? Eur J Gastroenterol Hepatol 2002; 14: 285-90.
25. Alberty J, Oelerich M, Ludwig K, Hartmann S, Stoll W. Efficacy of botulinum toxin A for treatment of upper esophageal sphincter dysfunction. Laryngoscope 2000; 110: 1151-6.
26. Haapaniemi JJ, Laurikainen EA, Pulkkinen J, Marttila RJ. Botulinum toxin in the treatment of cricopharyngeal dysphagia. Dysphagia 2001; 16: 171-5.
27. Shaw GY. Searl JP. Botulinum toxin treatment for cricopharyngeal dysfunction. Dysphagia 2001; 16: 161-7.
28. Terré R, Vallès M, Panadés A, Mearin F. Long-lasting effect of a single botulinum toxin injection in the treatment of oropharyngeal dysphagia secondary to upper esophageal sphincter dysfunction: a pilot study. Scand J Gastroenterol 2008; 43: 1296-303.
29. Crary MA, Mann GD, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil 2005; 86: 1516-20.
30. Logemann JA. Manual for the Videofluorographic Study of Swallowing, 2nd ed. Austin, TX: Pro-ed, 1993.
31. Logemann JA. Measurement of swallow from videofluorographic studies. In: Logemann JA, ed. Manual for the Videofluorographic Study of Swallowing, 2nd ed. Austin, TX: Pro-ed, 1993: 115-26.
32. Shaw DW, Cook IJ, Gabb M et al. Influence of normal aging on oral-pharyngeal and upper esophageal sphincter function during swallowing. Am J Physiol 1995; 268: 389-96.
33. Logemann JA, Pauloski BR, Rademaker AW, Colangelo LA, Kahrilas PJ, Smith CH. Temporal and biomechanical characteristics of oropharyngeal swallow in younger and older men. J Speech Lang Hear Res 2000; 43: 1264-74.
34. Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-aspiration scale. Dysphagia 1996; 11: 93-8.
35. Grupo español para el studio de la motilidad digestiva (GEEMD). Manometría esofágica convencional. In: Beages A, ed. Técnicas para el estudio de la actividad motora digestiva: protocolos metodológicos. Barcelona: Laboratorios Menarini, 1997: 11-25.
36. Granger CV, Hamilton BB, Kayton R. Guide for the Use of the Functional Independence Measure of the Uniform Data Set for Medical Rehabilitation. Buffalo, NY: Research Foundation of the State University of New York, 1989.
37. Spechler SJ. AGA technical review on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. Gastroenterology 1999; 117: 233-54.
38. Chiu MJ, Chang YC, Hsiao TY. Prolonged effect of botulinum toxin injection in the treatment of cricopharyngeal dysphagia: case report and literature review. Dysphagia 2004; 19: 52-7.
39. Kim DY, Park CI, Ohn SH, Moon JY, Chang WH, Park SW. Botulinum toxin type A for poststroke cricopharyngeal muscle dysfunction. Arch Phys Med Rehabil 2006; 87: 1346-51.
40. Terré R, Mearin F. Evolution of tracheal aspiration in severe traumatic brain injury-related oropharyngeal dysphagia: one-year longitudinal follow-up study. Neurogastroenterol Motil 2009; 21: 361-9.
41. Ravich WJ. Botulinum toxin for UES dysfunction: therapy or poison? Dysphagia 2001; 16: 168-70.
42. Restivo DA, Palmeri A, Marchese-Ragona R. Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease. N Engl J Med 2002; 346: 1174-5.
43. Restivo DA, Marchese-Ragona R, Patti F et al. Botulinum toxin improves dysphagia associated with multiple sclerosis. Eur J Neurol 2011; 18: 486-90.
44. Masiero S, Briani C, Marchese-Ragona R, Giacometti P, Costantini M, Zaninotto G. Successful treatment of long-standing post-stroke dysphagia with botulinum toxin and rehabilitation. J Rehabil Med 2006; 38: 201-3.
45. Kahrilas PJ, Logemann JA, Lin S, Ergun GA. Pharyngeal clearance during swallowing: a combined manometric and videofluoroscopic study. Gastroenterology 1992; 103: 128-36.
46. Ali GN, Wallace KL, Laundl TM, Hunt DR, de Carle DJ, Cook IJ. Predictors of outcome following cricopharyngeal disruption for pharyngeal dysphagia. Dysphagia 1997; 12: 133-9.
47. Krause E, Schirra J, Gürkov R. Botulinum toxin a treatment of cricopharyngeal dysphagia after subarachnoid hemorrhage. Dysphagia 2008; 23: 406-10.
48. Ghosh SK, Pandolfino JE, Zhang Q, Jarosz A, Kahrilas PJ. Deglutitive upper esophageal sphincter relaxation: a study of 75 volunteer subjects using solid-state high-resolution manometry. Am J Physiol Gastrointest Liver Physiol 2006; 291: G525-31.